Showing results (311-320 of 389) with videos related to
Sort By:
Pageof 39
Respiratory Investigation|December 3, 2014
Current status and future perspectives of cooperative study groups for lung cancer in JapanYuko Kawano, Isamu Okamoto, Haruhiko Fukuda, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.Clinical Lung Cancer|February 22, 2021
A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)Masayuki Takeda, Mototsugu Shimokawa, Atsushi Nakamura, et al.Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Phase II trial of weekly nab-paclitaxel for previously treated advanced non-small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301Shinya Sakata, Sho Saeki, Isamu Okamoto, et al.Lung Cancer (Amsterdam, Netherlands)|July 9, 2026
Adjuvant chemotherapy intensity and prognosis in completely resected high-grade neuroendocrine lung carcinoma: a post hoc analysis of JCOG1205/1206Tetsuya Isaka, Hirotsugu Kenmotsu, Masashi Wakabayashi, et al.Respirology (Carlton, Vic.)|September 1, 2025
Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary FibrosisKazuya Tsubouchi, Toyoshi Yanagihara, Fumiaki Kiyomi, et al.Respirology (Carlton, Vic.)|January 20, 2026
Epigenetic Dysregulation of the NKX2-1/SPDEF Axis Drives Persistent Goblet Cell Differentiation and Epithelial Barrier Dysfunction in Chronic Obstructive Pulmonary DiseaseAyaka Shiota, Keiko Kan-O, Yumiko Ishii, et al.Thoracic Cancer|September 9, 2024
A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non-small cell lung cancer (LOGIK1902)Taishi Harada, Tomonari Sasaki, Hidenobu Ishii, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2020
Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung CancerHirotsugu Kenmotsu, Nobuyuki Yamamoto, Takeharu Yamanaka, et al.Cancer|June 3, 2020
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L)Kaoru Tanaka, Satoshi Morita, Masahiko Ando, et al.Pageof 39